In pediatric, adolescent, and young adult patients, hematopoietic stem cell transplant was found to bolster overall survival.
Heme Today
Heme Today covers the latest news and analyses in bleeding, clotting, red blood cell, and iron disorders for hematologists and oncologists focused on bleeding disorders.
Advertisement
Latest News
Levels for certain inflammation biomarkers in patients with MDS were similar to in patients with autoinflammatory disorders.
The most common serious treatment-emergent adverse event among patients receiving either therapy was pneumonia.
A phase II trial calculated a 4-year event-free survival rate of 96% and overall survival rate of 100% from the combination.
Differences were identified between patient racial groups and by urban versus rural populations.
A magnetic resonance imaging study has compared tissue iron levels and biventricular function between the two conditions.
Lactate dehydrogenase level was pinpointed as a significant predictor of thromboembolism and mortality.
A study has assessed cryogenically preserved ovarian tissue samples from women with SCD for any effects from hydroxyurea.
A multicenter, double-blind, randomized study found no clinically significant difference in efficacy or safety.
A post-hoc analysis evaluated results of the complement component 3-targeted therapy in patients from three clinical trials.
A study has observed these genetic influences on disease outcome in MDS with isolated deletion of chromosome 5q.
Advertisement
Blood Cancer Awareness Month
A phase II trial calculated a 4-year event-free survival rate of 96% and overall survival rate of 100% from the combination.
Differences were identified between patient racial groups and by urban versus rural populations.
A magnetic resonance imaging study has compared tissue iron levels and biventricular function between the two conditions.
MDS Roundtables
Expert Interviews on Hematology
Conference Coverage
Heme Today reports from the EHA 2024 Hybrid Congress the latest findings in hematology research and management.
Highlighting the latest news and experts in pediatric hematology and oncology from the 2024 ASPHO Conference in Seattle.
Our editors are covering data on transplantation and cellular therapies from the 2024 Tandem Meetings of ASTCT® and ...
The editors of Heme Today review major presentations on classical hematology from the 2023 ASH Annual Meeting & ...
